TELADOC HEALTH, INC. Revenue from Contract with Customer, Including Assessed Tax
TELADOC HEALTH, INC. (TDOC) reported Revenue from Contract with Customer, Including Assessed Tax of $565.35 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-02.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2022-05-02
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2022-03-31 was $565.35M, a 24.62% increase year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2021-12-31 was $554.24M, a 44.59% increase year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2021-09-30 was $521.66M, a 80.62% increase year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for the quarter ending 2021-06-30 was $503.14M, a 108.75% increase year-over-year.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for fiscal 2021 was $2.03B, a 85.81% increase from fiscal 2020.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for fiscal 2020 was $1.09B, a 97.71% increase from fiscal 2019.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for fiscal 2019 was $553.31M, a 32.40% increase from fiscal 2018.
- TELADOC HEALTH, INC. revenue from contract with customer, including assessed tax for fiscal 2018 was $417.91M, a 79.14% increase from fiscal 2017.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2022-03-31 | $565.35M 10-Q · filed 2022-05-02 | $1.12B derived: sum of 2 quarters · filed 2022-05-02 | $1.64B derived: sum of 3 quarters · filed 2022-05-02 | $2.14B derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-12-31 | $554.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.08B derived: sum of 2 quarters · filed 2022-02-28 | $1.58B derived: sum of 3 quarters · filed 2022-02-28 | $2.03B 10-K · filed 2022-02-28 |
| 2021-09-30 | $521.66M 10-Q · filed 2021-11-01 | $1.02B derived: sum of 2 quarters · filed 2021-11-01 | $1.48B 10-Q · filed 2021-11-01 | $1.86B derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-06-30 | $503.14M 10-Q · filed 2021-08-02 | $956.81M 10-Q · filed 2021-08-02 | $1.34B derived: sum of 3 quarters · filed 2022-05-02 | $1.63B derived: sum of 4 quarters · filed 2022-05-02 |
| 2021-03-31 | $453.68M 10-Q · filed 2022-05-02 | $837.00M derived: sum of 2 quarters · filed 2022-05-02 | $1.13B derived: sum of 3 quarters · filed 2022-05-02 | $1.37B derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $383.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $672.13M derived: sum of 2 quarters · filed 2022-02-28 | $913.16M derived: sum of 3 quarters · filed 2022-02-28 | $1.09B 10-K · filed 2022-02-28 |
| 2020-09-30 | $288.81M 10-Q · filed 2021-11-01 | $529.84M derived: sum of 2 quarters · filed 2021-11-01 | $710.64M 10-Q · filed 2021-11-01 | $867.13M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $241.03M 10-Q · filed 2021-08-02 | $421.83M 10-Q · filed 2021-08-02 | $578.32M derived: sum of 3 quarters · filed 2021-08-02 | $716.29M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $180.80M 10-Q · filed 2021-05-03 | $337.29M derived: sum of 2 quarters · filed 2021-05-03 | $475.26M derived: sum of 3 quarters · filed 2021-05-03 | $605.53M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $156.49M 10-K · filed 2020-02-26 | $294.46M derived: sum of 2 quarters · filed 2020-11-06 | $424.73M derived: sum of 3 quarters · filed 2020-11-06 | $553.31M 10-K · filed 2022-02-28 |
| 2019-09-30 | $137.97M 10-Q · filed 2020-11-06 | $268.25M derived: sum of 2 quarters · filed 2020-11-06 | $396.82M 10-Q · filed 2020-11-06 | $519.56M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $130.28M 10-Q · filed 2020-07-29 | $258.85M 10-Q · filed 2020-07-29 | $381.59M derived: sum of 3 quarters · filed 2020-07-29 | $492.55M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $128.57M 10-Q · filed 2020-04-29 | $251.31M derived: sum of 2 quarters · filed 2020-04-29 | $362.28M derived: sum of 3 quarters · filed 2020-04-29 | $456.84M derived: sum of 4 quarters · filed 2020-04-29 |
| 2018-12-31 | $122.74M 10-K · filed 2020-02-26 | $233.70M derived: sum of 2 quarters · filed 2020-02-26 | $328.26M derived: sum of 3 quarters · filed 2020-02-26 | $417.91M 10-K · filed 2021-03-01 |
| 2018-09-30 | $110.96M 10-K · filed 2020-02-26 | $205.52M derived: sum of 2 quarters · filed 2020-02-26 | $295.17M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $94.56M 10-K · filed 2020-02-26 | $184.20M 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $89.64M 10-K · filed 2020-02-26 | |||
| 2017-12-31 | $233.28M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |